ABIRATERONE ACETATE | A210686 | MSN LABORATORIES PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BTG INTERNATIONAL LIMITED et al v. MSN PHARMACEUTICALS INC. et al 1 patentANDA 210686abiraterone acetate | D.N.J. | 2018-02-20 | Terminated 2019-05-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.02
per ea
Lowest NADAC/Unit
$0.8305
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 82009014060ABIRATERONE ACETATE 500 MG TAB | $3.02 | EA | Generic | — | 2026-06-17 |
| 68001067306ABIRATERONE ACETATE 500 MG TAB | $3.02 | EA | Generic | — | 2026-06-17 |
| 72205028560ABIRATERONE ACETATE 500 MG TAB | $3.02 | EA | Generic | — | 2026-06-17 |
| 72205028492ABIRATERONE ACETATE 250 MG TAB | $0.8305 | EA | Generic | — | 2026-06-17 |
| 82009013912ABIRATERONE ACETATE 250 MG TAB | $0.8305 | EA | Generic | — | 2026-06-17 |
| 68001048907ABIRATERONE ACETATE 250 MG TAB | $0.8305 | EA | Generic | — | 2026-06-17 |
| 72205003092ABIRATERONE ACETATE 250 MG TAB | $0.8305 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.